Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Up-titration of ACT-128800 in Healthy Subjects
NCT02029482Phase 1Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Apr 2010
- Primary completion
- Jun 2010
- Modality
- Covalent Small Molecules, Molecular Glues, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in multiple sclerosis (MS) comparing ACT-128800 with Placebo (2 arms). Primary endpoints: Systolic Blood Pressure at Day 18, Diastolic Blood Pressure at Day 18 and 2 more. Started Apr 2010; status: completed.
02
Drugs
ponesimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02029482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029482.